✦ LIBER ✦

207 SAFETY OF RIFAXIMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY: RESULTS OF A RANDOMIZED, PHASE 3, PLACEBO-CONTROLLED CLINICAL TRIAL

✍ Scribed by K. Mullen; S. Sigal; M. Sheikh; N. Bass; F. Poordad; K. Merchant; S. Huang; A. Shaw; E. Bortey; W. Forbes

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

15 RIFAXIMIN TREATMENT IMPROVED QUALITY

✍ A. Sanyal; N. Bass; K. Mullen; F. Poordad; A. Shaw; K. Merchant; E. Bortey; W.P. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 75 KB

93 RIFAXIMIN IS EFFECTIVE IN MAINTAINING

✍ N. Bass; K. Mullen; S. Sigal; A. Sanyal; F. Poordad; K. Merchant; S. Huang; A. S 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

66 Rifaximin Reduces the Risk of Hospita

✍ Guy Neff; Carroll B. Leevy; Todd Frederick; Kunal Merchant; Shirley Huang; Audre 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 158 KB

Su1687 Utility of the Hepatic Encephalop

✍ Hassanein, Tarek; Barakat, Fatma; Barrett, Andrew C.; Bortey, Enoch; Paterson, C 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 495 KB

Randomised clinical trial: rifaximin imp

✍ A. Sanyal; Z. M. Younossi; N. M. Bass; K. D. Mullen; F. Poordad; R. S. Brown; R. 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 471 KB

Rifaximin Improves Driving Simulator Per

✍ Jasmohan S. Bajaj; Douglas M. Heuman; James B. Wade; Douglas P. Gibson; Kia Saei 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 787 KB